Cargando…

Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema

In this retrospective study the morphological response of teleangiectatic capillaries (TCs) to focal laser treatment and the functional and morphological outcome after Indocyanine green angiography (ICGA)-guided laser therapy was evaluated. TCs in eyes with diabetic macular edema (DME) were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Datlinger, Felix, Datlinger, Anja, Pollreisz, Andreas, Sacu, Stefan, Schmidt-Erfurth, Ursula, Datlinger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831600/
https://www.ncbi.nlm.nih.gov/pubmed/35145156
http://dx.doi.org/10.1038/s41598-022-05950-0
_version_ 1784648541201760256
author Datlinger, Felix
Datlinger, Anja
Pollreisz, Andreas
Sacu, Stefan
Schmidt-Erfurth, Ursula
Datlinger, Peter
author_facet Datlinger, Felix
Datlinger, Anja
Pollreisz, Andreas
Sacu, Stefan
Schmidt-Erfurth, Ursula
Datlinger, Peter
author_sort Datlinger, Felix
collection PubMed
description In this retrospective study the morphological response of teleangiectatic capillaries (TCs) to focal laser treatment and the functional and morphological outcome after Indocyanine green angiography (ICGA)-guided laser therapy was evaluated. TCs in eyes with diabetic macular edema (DME) were treated with laser therapy. The immediate and subsequent reaction of the TCs lumina to direct photocoagulation was monitored with customized OCT single scans. Additionally, patients were treated with intravitreal anti-VEGF as needed. 12 eyes of 9 patients with treatment naive (6 eyes) and pretreated (6 eyes) DME were followed-up for a mean of 24 months (± 8.1SD). Best-corrected visual acuity improved from 0.25 logMar (± 0.2SD) to 0.12 (± 0.10SD; p = 0.06) at each patient’s last visit. During laser treatment a darkening of the TCs lumina was achieved in 91.3% of lesions. All these lesions fully resolved, whereas TCs, which showed no darkening of their lumen in OCT persisted and required re-treatment with laser. Additional anti-VEGF injections were indicated in only one eye (8.3%). The darkening of the TCs lumina visible in OCT might provide an image-biomarker that indicates successful coagulation of aneurysmatic lesions. Consequently, a significant functional and morphological improvement with need for anti-VEGF treatment in only one eye, was achieved. Information concerning the registration of the trial: date of registration: 11th of december, 2019. Trial registration number: 107/2019.
format Online
Article
Text
id pubmed-8831600
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88316002022-02-14 Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema Datlinger, Felix Datlinger, Anja Pollreisz, Andreas Sacu, Stefan Schmidt-Erfurth, Ursula Datlinger, Peter Sci Rep Article In this retrospective study the morphological response of teleangiectatic capillaries (TCs) to focal laser treatment and the functional and morphological outcome after Indocyanine green angiography (ICGA)-guided laser therapy was evaluated. TCs in eyes with diabetic macular edema (DME) were treated with laser therapy. The immediate and subsequent reaction of the TCs lumina to direct photocoagulation was monitored with customized OCT single scans. Additionally, patients were treated with intravitreal anti-VEGF as needed. 12 eyes of 9 patients with treatment naive (6 eyes) and pretreated (6 eyes) DME were followed-up for a mean of 24 months (± 8.1SD). Best-corrected visual acuity improved from 0.25 logMar (± 0.2SD) to 0.12 (± 0.10SD; p = 0.06) at each patient’s last visit. During laser treatment a darkening of the TCs lumina was achieved in 91.3% of lesions. All these lesions fully resolved, whereas TCs, which showed no darkening of their lumen in OCT persisted and required re-treatment with laser. Additional anti-VEGF injections were indicated in only one eye (8.3%). The darkening of the TCs lumina visible in OCT might provide an image-biomarker that indicates successful coagulation of aneurysmatic lesions. Consequently, a significant functional and morphological improvement with need for anti-VEGF treatment in only one eye, was achieved. Information concerning the registration of the trial: date of registration: 11th of december, 2019. Trial registration number: 107/2019. Nature Publishing Group UK 2022-02-10 /pmc/articles/PMC8831600/ /pubmed/35145156 http://dx.doi.org/10.1038/s41598-022-05950-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Datlinger, Felix
Datlinger, Anja
Pollreisz, Andreas
Sacu, Stefan
Schmidt-Erfurth, Ursula
Datlinger, Peter
Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title_full Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title_fullStr Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title_full_unstemmed Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title_short Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
title_sort intraprocedural oct monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831600/
https://www.ncbi.nlm.nih.gov/pubmed/35145156
http://dx.doi.org/10.1038/s41598-022-05950-0
work_keys_str_mv AT datlingerfelix intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema
AT datlingeranja intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema
AT pollreiszandreas intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema
AT sacustefan intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema
AT schmidterfurthursula intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema
AT datlingerpeter intraproceduraloctmonitoringoftheimmediatetreatmentresponseduringindocyaninegreenangiographyguidedlasertherapyofteleangiectaticcapillariesindiabeticmacularedema